MARKET

TENX

TENX

Tenax Therapeut
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.218
-0.010
-0.81%
Closed 16:00 12/13 EST
OPEN
1.213
PREV CLOSE
1.228
HIGH
1.220
LOW
1.190
VOLUME
35.56K
TURNOVER
--
52 WEEK HIGH
2.790
52 WEEK LOW
1.030
MARKET CAP
8.09M
P/E (TTM)
-0.2028
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TENX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TENX News

  • TENX: Tenax HELP Update
  • Zacks Small Cap Research.11/04 15:45
  • KHC, SPWR among premarket gainers
  • Seeking Alpha - Article.10/31 13:12
  • Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial
  • Business Wire.10/31 13:00
  • Tenax Therapeutics Offers Update On Phase 2 Pulmonary Hypertension Clinical Trial
  • Benzinga.10/31 12:05

More

Industry

Biotechnology & Medical Research
-0.88%
Pharmaceuticals & Medical Research
-0.08%

Hot Stocks

Name
Price
%Change

About TENX

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure. Levosimendan represents therapeutic modalities for the treatment of Low Cardiac Output Syndrome (LCOS), septic shock and other critical care conditions. The therapeutic effects of levosimendan are mediated through increased cardiac contractility by calcium sensitization of troponin C, resulting in a positive inotropic effect, which is not associated with substantial increases in oxygen demand; opening of potassium channels in the vasculature smooth muscle, resulting in a vasodilatory effect on all vascular beds, and opening of mitochondrial potassium channels in cardiomyocytes, resulting in a cardioprotective effect.
More

Webull offers Tenax Therapeutics Inc (TENX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.